Uveitis, also known as iridocyclitis and chorioretinitis, is an inflammatory eye disease involving multiple tissues of the iris, ciliary body, choroid, and retina. Uveitis is a common blinding eye disease with a blindness rate of 1.1-9.2%. The etiology of uveitis is diverse and the pathogenesis complex, and it is now recognized that immune factors play an important and critical role in uveitis. Autoimmune diseases are diseases caused by the body’s immune response to its own antigens, resulting in damage to its own tissues. A variety of autoimmune diseases occur with uveitis, including rheumatoid arthritis, ankylosing spondylitis, leukoarthrosis, psoriasis, inflammatory bowel disease, and multiple sclerosis. Clinical symptoms of uveitis include eye redness, eye pain, photophobia and tearing, blurred vision, etc. Eye examination may reveal conjunctival congestion, intraocular inflammatory cells, and even pus accumulation in the eye. Repeated attacks may lead to complications such as post-iris adhesion, cataract, and glaucoma. Treatment of uveitis usually requires both local and systemic medications. Hormones and immunosuppressants have a variety of side effects, and irregular and irregular treatment not only fails to control inflammation, but can also lead to recurrence of inflammation and complications, which can seriously affect the patient’s work and study. Therefore, it is advisable for patients with uveitis to go to a hospital for standardized treatment and follow-up to avoid delaying the condition.